COLL vs DKNG · P/E 17, rev $181.9M vs rev $4.77B
Collegium Pharmaceutical Inc (COLL) versus DraftKings Inc (DKNG) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
DraftKings Inc (DKNG) is a gambling company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported DKNG revenue for 2024-12-31 was $4.77B. Net income was -$507.3M. Revenue was up 30.1% from 2023-12-31 to 2024-12-31. DKNG currently screens at market cap $20.96B.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. DKNG currently screens at market cap $20.96B.
Not investment advice. Open the COLL and DKNG stock pages for the full models.
Not investment advice.